Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.15B
+25.8% from 2023
Prescriptions
99K
$21,796.49 per claim
Patients
14K
7,717 prescribers
Total spending, 2024
$2.15B
$150,103.44 per patient
Medicare prescription drug plans paid $2.15B for Pomalyst in 2024, for 98,604 prescriptions and refills to 14,317 patients (up 25.8% from 2023). The average cost per claim was $21,796.49.
California had the highest Medicare cost for Pomalyst in 2024: $220.2M for 9,817 claims, followed by Florida ($174.1M).
Harsh Parmar, medical oncology in Hackensack, NJ, had the highest Medicare cost for Pomalyst in 2024: 421 claims costing $8.1M.
Pomalyst is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Harsh Parmar Hackensack, NJ | Medical Oncology | 421 | 100 | $8.1M |
| Suzan Rosen Miami, FL | Nurse Practitioner | 323 | 50 | $7.4M |
| David S Siegel Hackensack, NJ |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,931 | 86,135 | 12,676 | $1.74B |
| 2023 | 7,108 | 78,680 | 12,722 | $1.71B |
| 2024 | 7,717 | 98,604 | 14,317 | $2.15B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 271 |
| 89 |
| $5.0M |
| Jayesh Mehta Chicago, IL | Hematology | 234 | 37 | $5.0M |
| Larry D Anderson Jr. Dallas, TX | Hematopoietic Cell Transplantation and Cellular Therapy | 228 | 33 | $4.9M |
| Maurizio Zangari Little Rock, AR | Hematology-Oncology | 217 | 34 | $4.9M |
| Catharine E Skoog Milwaukee, WI | Physician Assistant | 213 | 39 | $4.8M |
| Craig C Hofmeister Atlanta, GA | Hematology | 204 | 32 | $4.6M |
| Ami P Ndiaye Charlotte, NC | Nurse Practitioner | 199 | 53 | $4.5M |
| Rachid C Baz Tampa, FL | Hematology-Oncology | 190 | 34 | $4.4M |
| Kevin Brigle Richmond, VA | Nurse Practitioner | 197 | 27 | $4.3M |
| Emerentia A Agyemang Boston, MA | Nurse Practitioner | 201 | 32 | $4.1M |
| Erica L Campagnaro Ann Arbor, MI | Hematology | 177 | 37 | $4.0M |
| Jordan D Robinson Charlotte, NC | Physician Assistant | 175 | 55 | $3.9M |
| Ajay K Nooka Atlanta, GA | Hematology-Oncology | 161 | 23 | $3.8M |
| Al-Ola A Abdallah Tulsa, OK | Hematology | 183 | 32 | $3.7M |
| Jason Valent Strongsville, OH | Hematology-Oncology | 162 | 27 | $3.5M |
| Tina A Flaherty Boston, MA | Nurse Practitioner | 167 | 36 | $3.3M |
| Cristina Gasparetto Durham, NC | Hematology-Oncology | 145 | 18 | $3.3M |
| Frits Van Rhee Little Rock, AR | Hematology | 157 | 24 | $3.2M |
| Michael M Green Baltimore, MD | Hematology-Oncology | 132 | 15 | $3.2M |
| Jonathan L Kaufman Atlanta, GA | Hematology-Oncology | 134 | 25 | $3.1M |
| Kerry L Bondy Ann Arbor, MI | Physician Assistant | 135 | 31 | $3.1M |
| Brett T Brinker Grand Rapids, MI | Hematology-Oncology | 132 | 25 | $3.0M |
| Areyl D Goff Milwaukee, WI | Nurse Practitioner | 130 | 36 | $2.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 98,648 | $2.15B |